首页 | 官方网站   微博 | 高级检索  
     

微生态制剂“培菲康”治疗小儿感染性腹泻及便秘100例临床研究
引用本文:王树山,徐光芝.微生态制剂“培菲康”治疗小儿感染性腹泻及便秘100例临床研究[J].中国微生态学杂志,1996,8(4):35-37.
作者姓名:王树山  徐光芝
作者单位:首都儿科研究所附属儿童医院
摘    要:培菲康为双歧杆菌、嗜酸乳杆菌、粪链球菌组成的人体肠道微生态活菌制剂,本文采用此制剂治疗小儿菌痢22例,有效率81.82%;小儿肠炎47例,有效率86.6%;便秘31例,有效率达87.1%。全部100例,总有效率为86%。所有病例未用抗菌药物。本文对微生态药物培菲康的药理作用及特点进行了讨论。

关 键 词:培菲康,感染性腹泻,细菌性痢疾,肠炎,便秘

THE EFFECTS OF BIFICO IN TREATMENT OF CHILDREN'S INFECTIOUS DIARRHEA AND CONSTIPATION IN 100 CASES
Wang Shushan,et al..THE EFFECTS OF BIFICO IN TREATMENT OF CHILDREN'S INFECTIOUS DIARRHEA AND CONSTIPATION IN 100 CASES[J].Chinese Journal of Microecology,1996,8(4):35-37.
Authors:Wang Shushan  
Abstract:BIFICO consists principally of Bifidobacterium bifidum,Lactobacillus acidophilus and Streptococcus faecalis,which are the normal bacterial species in the intestine of healthy human beings.100 cases patients with infectious diarrhea and constipaton treated by BIFICO were reported.The total effective rate was 86%.The effective rate of acute desentery was 81.82%.The effective rate of enteritis was 86.60%,The effective rate of constipation was 87.10%,The biological function and significance of BIFICO were discussed.
Keywords:BIFICO Infectious diarrhea Acute disentery Constipation  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号